IMCR · Immunocore Holdings plc
$34.21
+0.01 (+0.03%)
At close · Aug 14
Market Cap
$1.76B
Shares
51.50M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Bahija Jallal | Chief Executive Officer | $10,885,268 |
| Travis Coy | Chief Financial Officer | $5,171,209 |
| David Berman | M.D., Ph.D. Former Executive Vice President, Head of Research & Development | $4,278,988 |
| Tina St. Leger | Chief Human Resources Officer | $1,204,261 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Bahija Jallal | Chief Executive Officer | $12,852,234 |
| David Berman | M.D., Ph.D. Executive Vice President, Head of Research & Development | $5,481,495 |
| Brian Di Donato | Former Chief Financial Officer | $3,439,339 |
| Tina St. Leger | Chief Human Resources Officer | $1,115,871 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Bahija Jallal | Chief Executive Officer | $11,678,834 |
| David Berman | M.D., Ph.D. Executive Vice President, Head of Research & Development | $4,396,622 |
| Brian Di Donato | Former Chief Financial Officer | $3,354,443 |
| Tina St. Leger | Chief Human Resources Officer | $1,039,117 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Bahija Jallal | Chief Executive Officer | $8,008,503 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Bahija Jallal | Chief Executive Officer | $34,783,285 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| David Berman | Head of Research & Development | Resigned | 2026-01-30 |
| Tina St. Leger | Chief Human Resources Officer | Resigned | 2025-11-28 |
| Ranjeev Krishana | member of the Board | Resigned | 2025-11-28 |
| William Pao, M.D., Ph.D. | Class II director | Appointed | 2025-02-26 |
| Travis Coy | board of directors | Resigned | 2025-01-02 |
| Travis Coy | Executive Vice President, Chief Financial Officer and Head of Corporate Development | Appointed | 2025-01-02 |
| Brian Di Donato | Executive Vice President, Chief Financial Officer and Head of Strategy and principal financial officer | Resigned | 2024-08-29 |
| Ranjeev Krishana | Class I director | Appointed | 2024-05-28 |
Key facts
CIK
1671927
CUSIP
45258D105
13F (30d)
135 filings
127 filers
Visit website
Investor relations